Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents

NCT01461824 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT01461824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01461824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
July 31, 2016
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of bone density and structure, unspecified, uterine bleeding, weight gain